Publication date: Jan 24, 2025
Summary: A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two years after infection. Key Impairments: PCS is associated with reduced exercise capacity, memory, and attention. PCS is associated with reduced exercise capacity, memory, and attention.
| Concepts | Keywords |
|---|---|
| Dehydroepiandrosterone | Acute |
| January | Capacity |
| Obesity | Cognitive |
| Outpatient | Covid |
| Pcr | Exercise |
| Infection | |
| Long | |
| Participants | |
| Pcs | |
| Persistent | |
| Post | |
| Reduced | |
| Reported | |
| Symptoms | |
| Syndrome |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Long COVID |
| disease | MESH | COVID-19 |
| disease | MESH | syndrome |
| disease | MESH | infection |
| disease | MESH | obesity |
| drug | DRUGBANK | Oxygen |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | breathlessness |
| disease | MESH | anxiety |
| disease | MESH | depression |
| disease | MESH | educational attainment |
| disease | IDO | role |
| disease | IDO | acute infection |
| disease | MESH | myalgic encephalomyelitis |
| disease | MESH | dysautonomia |
| disease | MESH | sleep quality |
| disease | IDO | quality |
| drug | DRUGBANK | Carbon dioxide |
| disease | IDO | production |
| disease | IDO | blood |
| drug | DRUGBANK | Hydrocortisone |
| drug | DRUGBANK | Corticotropin |
| drug | DRUGBANK | Prasterone sulfate |
| disease | MESH | comorbidity |
| disease | MESH | adrenal insufficiency |
| disease | IDO | history |
Original Article
(Visited 2 times, 1 visits today)